Allergy, Asthma & Immunology Associates of Tampa Bay — Tampa, Florida

Allergy, Asthma & Immunology Associates of Tampa Bay is a clinical research site located in Tampa, Florida, United States 33613.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Allergy, Asthma & Immunology Associates of Tampa Bay has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Allergy, Peanut Allergy, Clonal Mast Cell Disease.

Sponsors: DBV Technologies, Blueprint Medicines Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allergy, Asthma & Immunology Associates of Tampa Bay?

Allergy, Asthma & Immunology Associates of Tampa Bay has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allergy, Asthma & Immunology Associates of Tampa Bay conducted?

Allergy, Asthma & Immunology Associates of Tampa Bay has 2 clinical trials on record, with 2 currently active. Their work covers Allergy, Peanut Allergy, Clonal Mast Cell Disease.

Is Allergy, Asthma & Immunology Associates of Tampa Bay accredited by Crixeo Clinical Trials?

Allergy, Asthma & Immunology Associates of Tampa Bay has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allergy, Asthma & Immunology Associates of Tampa Bay?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.